Nikulski Financial, Inc. Abbott Laboratories Transaction History

Nikulski Financial, Inc.

$331 Million
Q3 2024

A detailed history of Nikulski Financial, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Nikulski Financial, Inc. holds 10,016 shares of ABT stock, worth $1.13 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

10,016

Previous 9,792 2.29%

Holding current value

$1.13 Million

Previous $1.02 Million 12.19%

% of portfolio

0.34%

Previous 0.32%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$100.07 - $118.13 $22,415 - $26,461	224 Added 2.29%	10,016 $1.14 Million
Q2 2024 Jul 30, 2024	SELL	$100.73 - $112.44 $117,954 - $131,667	-1,171 Reduced 10.68%	9,792 $1.02 Million
Q1 2024 Apr 18, 2024	SELL	$109.52 - $120.96 $9,856 - $10,886	-90 Reduced 0.81%	10,963 $1.25 Million
Q4 2023 Feb 01, 2024	SELL	$90.19 - $110.4 $10,371 - $12,696	-115 Reduced 1.03%	11,053 $1.22 Million
Q3 2023 Oct 17, 2023	BUY	$95.53 - $114.62 $85,403 - $102,470	894 Added 8.7%	11,168 $1.08 Million
Q2 2023 Jul 27, 2023	BUY	$100.78 - $112.29 $88,182 - $98,253	875 Added 9.31%	10,274 $1.12 Million
Q1 2023 May 11, 2023	BUY	$96.86 - $114.01 $169,020 - $198,947	1,745 Added 22.8%	9,399 $951,000
Q4 2022 Jan 25, 2023	BUY	$95.06 - $111.52 $107,893 - $126,575	1,135 Added 17.41%	7,654 $0
Q3 2022 Oct 20, 2022	BUY	$96.76 - $112.03 $35,317 - $40,890	365 Added 5.93%	6,519 $631,000
Q2 2022 Jul 19, 2022	BUY	$102.07 - $123.37 $67,366 - $81,424	660 Added 12.01%	6,154 $669,000
Q1 2022 Apr 08, 2022	BUY	$114.02 - $139.04 $80,384 - $98,023	705 Added 14.72%	5,494 $650,000
Q4 2021 Feb 01, 2022	SELL	$115.53 - $141.46 $693 - $848	-6 Reduced 0.13%	4,789 $674,000
Q3 2021 Nov 05, 2021	SELL	$116.66 - $129.06 $11,316 - $12,518	-97 Reduced 1.98%	4,795 $566,000
Q2 2021 Aug 11, 2021	SELL	$105.79 - $124.53 $2,644 - $3,113	-25 Reduced 0.51%	4,892 $582,000
Q4 2020 Feb 09, 2021	BUY	$105.0 - $114.42 $169,155 - $184,330	1,611 Added 48.73%	4,917 $538,000
Q2 2020 Jul 17, 2020	SELL	$76.57 - $98.0 $20,444 - $26,166	-267 Reduced 7.47%	3,306 $302,000
Q1 2020 Apr 29, 2020	BUY	$62.82 - $91.86 $9,423 - $13,779	150 Added 4.38%	3,573 $282,000
Q4 2019 Feb 04, 2020	BUY	$78.51 - $87.4 $33,994 - $37,844	433 Added 14.48%	3,423 $305,000
Q2 2019 Jul 22, 2019	SELL	$72.88 - $85.0 $14,576 - $17,000	-200 Reduced 6.27%	2,990 $256,000
Q3 2018 Nov 02, 2018	SELL	$60.81 - $73.36 $30,405 - $36,680	-500 Reduced 13.55%	3,190 $220,000
Q2 2018 Aug 10, 2018	SELL	$57.57 - $63.54 $28,785 - $31,770	-500 Reduced 11.93%	3,690 $225,000
Q4 2017 Feb 09, 2018	BUY	$53.68 - $57.47 $224,919 - $240,799	4,190	4,190 $239,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $198B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nikulski Financial, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nikulski Financial, Inc. with notifications on news.

Account

Nikulski Financial, Inc. Abbott Laboratories Transaction History